Literature DB >> 27938682

Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c Mice.

Maryam Golshani1, Sima Rafati2, Mehdi Nejati-Moheimani3, Melina Ghasemian1, Saeid Bouzari4.   

Abstract

In the present study, immunogenicity and protective efficacy of the Brucella outer membrane protein 2b (Omp2b) was evaluated in BALB/c mice using Protein/Protein, DNA/DNA and DNA/Protein vaccine strategies. Immunization of mice with three vaccine regimens elicited a strong specific IgG response (higher IgG2a titers over IgG1 titers) and provided Th1-oriented immune response. Vaccination of BALB/c mice with the DNA/Pro regimen induced higher levels of IFN-γ/IL-2 and conferred more protection levels against B. melitenisis and B. abortus challenge than did the protein or DNA alone. In conclusion, Omp2b is able to stimulate specific immune responses and to confer cross protection against B. melitensis and B. abortus infection. Therefore, it could be introduced as a new potential candidate for the development of a subunit vaccine against Brucella infection.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brucella abortus; Brucella melitensis; Cross protection; DNA vaccine; Omp2b; Prime-boost strategy; Recombinant protein

Mesh:

Substances:

Year:  2016        PMID: 27938682     DOI: 10.1016/j.vetmic.2016.10.027

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB/c mice.

Authors:  Guo-Zhen Lin; Ju-Tian Yang; Suo-Cheng Wei; Shi-En Chen; Sheng-Dong Huo; Zhong-Ren Ma
Journal:  Trop Anim Health Prod       Date:  2018-02-28       Impact factor: 1.559

2.  In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens.

Authors:  Maryam Golshani; Melina Ghasemian; Nematollah Gheibi; Saeid Bouzari
Journal:  Adv Biomed Res       Date:  2018-02-16

3.  The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice.

Authors:  Fengbo Zhang; Zhiwei Li; Bin Jia; Yuejie Zhu; Pan Pang; Chuntao Zhang; Jianbing Ding
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

4.  Epitope-Based Vaccine of a Brucella abortus Putative Small RNA Target Induces Protection and Less Tissue Damage in Mice.

Authors:  Karen Cristina Oliveira; Gustavo Andrade Brancaglion; Natália C M Santos; Leonardo P Araújo; Evandro Novaes; Renato de Lima Santos; Sergio Costa Oliveira; Patrícia Paiva Corsetti; Leonardo Augusto de Almeida
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

Review 5.  Evaluation of Brucellosis Vaccines: A Comprehensive Review.

Authors:  Mohsen Heidary; Shirin Dashtbin; Roya Ghanavati; Marzie Mahdizade Ari; Narjess Bostanghadiri; Atieh Darbandi; Tahereh Navidifar; Malihe Talebi
Journal:  Front Vet Sci       Date:  2022-07-18

6.  A review of Brucellosis in Iran: Epidemiology, Risk Factors, Diagnosis, Control, and Prevention

Authors:  Maryam Golshani; Saeid Buozari
Journal:  Iran Biomed J       Date:  2017-08-02

7.  Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

Authors:  Augusto E Bivona; Andrés Sánchez Alberti; Marina N Matos; Natacha Cerny; Alejandro C Cardoso; Celina Morales; Germán González; Silvia I Cazorla; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2018-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.